 |
Search Term: Oligodendroglioma High Grade
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
|
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
05/28/2008 |
|
|
|
|
|
Details |
|
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
|
Houston, TX |
|
05/28/2008 |
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
04/16/2008 |
|
|
|
|
|
Details |
|
A Phase I Dose-Finding and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients with Recurrent or Refractory Glioma, with or without Concurrent Treatment with Enzyme-Inducing Anticonvulsant Drug Therapy.
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma |
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
Los Angeles, CA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA |
|
03/02/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Kingston, Ontario, CANADA
Edmonton, Alberta, CANADA
Halifax, Nova Scotia, Canada
Moncton, New Brunswick, CANADA
Ottawa, Ontario, CANADA
Toronto, Ontario, CANADA
Winnipeg, Manitoba, CANADA
Phoenix, AZ
La Jolla, CA
Palo Alto, CA
Sacramento, CA
Aurora, CO
Englewood, CO
Jacksonville, FL
Orlando, FL
Chicago, IL
Evanston, IL
Boston, MA
Detroit, MI
Winston-Salem, NC
Edison, NJ
Buffalo, NY
Columbus, OH
Columbus, OH
Portland, OR
Memphis, TN
Nashville, TN
Seattle, WA
Madison, WI |
|
03/01/2008 |
|
|
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA |
|
01/17/2008 |
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
Details |
|
Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab (Avastin) in Combination With Irinotecan (CPT-11) for Malignant Gliomas |
|
Durham, NC |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY |
|
08/20/2007 |
|
|
|
Details |
|
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
|
Durham, NC |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL |
|
08/20/2007 |
|
|
|
Details |
|
Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration |
|
Baltimore, MD |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute`s (NCI) Clinical Research Protocols |
|
Bethesda, MD |
|
08/20/2007 |
|
|
|
Details |
|
The Temozolomide RESCUE Study: A Phase II Trial of Continuous (28/28) Dose-Intense Temozolomide (CDIT) Chemotherapy After Progression on Conventional 5/28 Day Temozolomide in Patients With Recurrent Malignant Glioma |
|
Toronto, Ontario, CANADA |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone |
|
Bethesda, MD |
|
08/19/2007 |
|
|
|
Details |
|
A Phase II Trial of BEVACIZUMAB for Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy |
|
Copenhagen, Denmark |
|
08/18/2007 |
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme |
|
Houston, TX |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings |
|
Cleveland, OH |
|
08/18/2007 |
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA
Durham, NC |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas. |
|
Montreal, Canada |
|
08/18/2007 |
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma |
|
Los Angeles, CA |
|
08/04/2007 |
|
|
|
|
|
Details |
|
Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Tampa, FL
Atlanta, GA
Chicago, IL
Boston, MA
Detroit, MI
Durham, NC
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Birmingham, AL
Tampa, FL
Boston, MA
Baltimore, MD
Detroit, MI
Detroit, MI
Winston-Salem, NC
Philadelphia, PA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
|
Cleveland, OH
Columbus, OH
Portland, OR |
|
05/01/2007 |
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Jacksonville, FL
Boston, MA
Rochester, MN
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Talampanel in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD |
|
04/29/2007 |
|
|
|
Details |
|
RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma |
|
Los Angeles, CA
Dallas, TX |
|
11/21/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
|
New York, NY |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
,
, Canada
, Canada
, Canada
, Canada
, Canada
, Canada
, Switzerland
, Switzerland
Auckland, New Zealand
Perth, Western Australia, 6001, Australia
Randwick, New South Wales, 2031, Australia
Phoenix, AZ
Downey, CA
Loma Linda, CA
Los Angeles, CA
Los Angeles, CA
Los Angeles, CA
Madera, CA
Oakland, CA
Orange, CA
Orange, CA
Sacramento, CA
San Francisco, CA
Santa Barbara , CA
Travis Air Force Base, CA
Denver, CO
Farmington, CT
Washington, DC
Washington, DC
Wilmington, DE
Atlanta, GA
Macon, GA
Savannah, GA
Des Moines, IA
Chicago, IL
Chicago, IL
Park Ridge, IL
Indianapolis, IN
Springfield, MA
Baltimore, MD
Ann Arbor, MI
Detroit, MI
Grand Rapids, MI
Kalamazoo, MI
Royal Oak, MI
Royal Oak, MI
Minneapolis, MN
Rochester, MN
Kansas City, MO
Chapel Hill, NC
Charlotte, NC
Winston-Salem, NC
Fargo, ND
Omaha, NE
Omaha, NE
Brunswick, NJ
Newark, NJ
Paterson, NJ
Summit, NJ
Las Vegas, NV
Albany, NY
Bronx, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
New Hyde Park, NY
New York, NY
Stony Brook, NY
Syracuse, NY
Akron, OH
Cincinnati, OH
Cleveland, OH
Columbus, OH
Dayton, OH
Toledo, OH
Portland, OR
Danville, PA
Philadelphia, PA
Pittsburgh, PA
Sioux Falls, SD
Johnson City, TN
Knoxville, TN
Nashville, TN
Amarillo, TX
Austin, TX
Dallas, TX
Houston, TX
Lubbock, TX
San Antonio, TX
San Antonio, TX
Temple, TX
Norfolk, VA
Seattle, WA
Seattle, WA
Spokane, WA
Tacoma, WA
Green Bay, WI
Green Bay, WI
Green Bay, WI
La Crosse, WI
Madison, WI
Marshfield, WI
Marshfield, WI
Huntington, WV |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Jacksonville, FL
Jacksonville, FL
Des Moines, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Rochester, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Danville, PA
Spartanburg, SC
Sioux Falls, SD
Charlottesville, VA |
|
06/26/2006 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas |
|
Bethesda, MD |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
|
Los Angeles, CA |
|
05/29/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
05/04/2006 |
|
|
|
Details |
|
A Phase I Trial Using Combination Irinotecan (CPT-11) and Thalidomide for Recurrent CNS Tumors |
|
Albuquerque, NM |
|
05/02/2006 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of Depsipeptide (FK228) in Patients with High-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
Details |
|
A Phase II Trial of Tamoxifen and Bortezomib (Velcade) in Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
|
|
Details |
|
A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas |
|
Durham, NC |
|
05/01/2006 |
|
|
|
Details |
|
Phase I/II Study of ZD6474(Zactima) in Patients With Recurrent High-Grade or Progressive Low-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
|
Chicago, IL |
|
05/01/2006 |
|
|
|
Details |
|
Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas
|
|
Seattle, WA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Chicago, IL
Bethesda, MD
Bethesda, MD
Durham, NC
Durham, NC
Lincoln, NE
Philadelphia, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery |
|
Chicago, IL |
|
04/30/2006 |
|
|
|
Details |
|
Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma.
|
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Pharmacological intervention for learning impaired children surviving treatment for cancer. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA |
|
12/03/2005 |
|
|
|
Details |
|
Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
|
New York, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Edison, NJ |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY |
|
12/03/2005 |
|
|
|
Details |
|
Phase I/II Study of Multiple Light Fiber Interstitial Photodynamic Therapy for Primary and Metastatic Supratentorial Brain Tumors |
|
Hershey, PA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Quality of Life Studies (There are 19 seperate studies listed here) |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Use of Epilepsy Monitoring And Electrocorticography For Seizure Control In Patients With Brain Tumors |
|
Hackensack, NJ |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I Trial of CC-8490 for the Treatment of Patients with Recurrent/Refractory High-Grade Gliomas |
|
Bethesda, MD |
|
11/27/2005 |
|
|
|
Details |
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
|
Bethesda, MD
Bethesda, MD |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Bethesda, MD
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
11/27/2005 |
|
|
|
Details |
|
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas |
|
Lanne, Switzerland |
|
11/27/2005 |
|
|
|
Details |
|
Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer. |
|
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Endoscopic ventriculostomy for obstructive hydrocephalus in terminal patients with hydrocephalus and brain tumours. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Feasibility of using oral Etoposide combined with escalating doses of Tamoxifen for children with recurrent gliomas |
|
Denver, CO |
|
11/27/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Surgery For Brain Tumors |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Functional brain Mapping Of Motor And Speech Areas For Resection Of Tumors Near Functional Areas Of The Brain |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Genetic Therapy of meningiomas and gliomas in the Malay population in the NorthnEast coast of Malaysia |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Jacksonville, FL
Ames, IA
Cedar Rapids, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Duluth, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Allentown, PA
Danville, PA
Sayre, PA
Spartanburg, SC
Rapid City, SD
Sioux Falls, SD |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research |
|
Zürich , Switzerland
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Regulus Navigator for use with a three point pinion - frameless stereotactic surgery |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Risk Adapted, Multimodal Therapy In Newly Diagnosed Supratentorial Malignant Glioma, Stratified To KPS. |
|
Kreischa Dresden, GERMANY |
|
11/27/2005 |
|
|
|
Details |
|
Volumetric Stereotactic Procedures |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Adoptive IL-2 activated LAK cell intratumoral immunotherapy implant with adjuvant radiosurgery boost and naturopathic/nutritional immune enhancement. This is for newly diagnosed patients only.
|
|
Newport Beach, CA |
|
11/26/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors and Arteriovenous and Cavernous Malformations |
|
St.Petersburg, Fl |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Intra-arterial carboplatin for supratentorial brain tumors |
|
Fort Worth, TX |
|
11/26/2005 |
|
|
|
Details |
|
Aggresive emergency tumour debulking and craniectomy for patients with tumours of more than 80ml and glasgow coma scale of less than 8. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
|
| | |
